Add to a list

Inactive Instrument

POLI BANK Share Price

BKM

PLPBKM000012

Healthcare Facilities & Services

on all subscriptions*

Exceptional extension!

Enjoy this offer

* See conditions under "Our services"

Polski Bank Komorek Macierzystych SA (PBKM) is a Poland-based company that carries out full set of researches from umbilical cord blood. PBKM is the cord blood bank in Poland, which is one of public and private cord banks in Europe accredited by American Association of Blood Banks (AABB). The Company cooperates with the Institute of Human Genetics PAS (Polish Academy of Sciences), Medicover, LUX MED Salus Clinic, Medical Centers Salve, as well as Falck Sp z o o and Alab Laboratories, among others. The public cord blood bank aims to increase the resources of the stored cord blood and the use of cord blood for transplantation in Poland. The Company forms a part of the international group of banks of stem cells from umbilical cord blood, FamiCord, which consists of laboratories in Poland, Hungary, Romania, Spain and Turkey, and which collaborates with over 1100 hospitals throughout Europe.

Employees

592

Sector

Healthcare Facilities & Services

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!

15/09/25	Polski Bank Komórek Macierzystych S.A. entered into a share sale agreement to acquire Wn Novum Spolka Z Ograniczona Odpowiedzialnoscia from Family Foundation Novum and Jan Lewandowski.	CI
27/05/25	Polski Bank Komórek Macierzystych S.A. agreed entered into an agreement to acquire additional 69% stake in Národní centrum pupecníkové krve and Rodinná banka perinatálnych a mezenchymálnych buniek s.r.o from PrimeCell Advanced Therapy, a.s.	CI
07/02/22	Famicordtx S.A. announced that it has received €3.5 million in funding from NextCell Pharma AB, Polski Bank Komórek Macierzystych S.A. and other investors	CI
14/11/21	VITA 34 AG completed the acquisition of Polski Bank Komórek Macierzystych S.A from from AOC Health GmbH, Jakub Baran, Tomasz Baran and others.	CI
08/11/21	Polski Bank Kom?rek Macierzystych S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
20/09/21	Vita 34 : Commences Offer Period for Polski Bank Komorek Takeover	MT
31/08/21	Polski Bank Komórek Macierzystych S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
13/07/21	Polski Bank Komórek Macierzystych S.A. announced that it expects to receive PLN 0.01724 million in funding	CI
08/07/21	Polski Bank Komórek Macierzystych S A : Ominvest Receives Watchdog Approval To Increase Stake In Bank Muscat	MT
22/06/21	NextCell Pharma AB Enters CAR-T Joint Venture	CI
31/05/21	Vita 34 : Polski Bank Komorek Agree To Merge Via Share Swap	MT
30/05/21	VITA 34 AG entered into a Business Combination Agreement to acquire Polski Bank Komórek Macierzystych S.A. from AOC Health GmbH, Jakub Baran, Tomasz Baran and others for approximately PLN 840 million.	CI
27/05/21	Polski Bank Komórek Macierzystych S.A. agreed to acquire 80% stake in Smart Cells Holdings Limited for PLN 21.1 million.	CI

20/09/21	Polski Bank Komórek Macierzystych S A : Pdf Vita 34 AG launches voluntary public exchange offer for PBKM shares press release (204 KB)	PU
02/09/21	Polski Bank Komórek Macierzystych S A : Pdf FamiCord Group invest in Smart Cells UK press release (250 KB)	PU
29/08/21	Polski Bank Komórek Macierzystych S A : FamiCord Group investing in stem cell bank owned by Smart Cells Holdings Limited, UK	PU
02/04/21	Polski Bank Komórek Macierzystych S A : Pdf PBKM Group financial results in 2020 press release (277 KB)	PU

Manager	Title	Age	Since
Jakub Julian Baran CEO	Chief Executive Officer	54	-
Adam Kalkusinski IRC	Investor Relations Contact	55	-
Tomasz Oldak CTO	Chief Tech/Sci/R&D Officer	-	31/12/2016

Director	Title	Age	Since
Tomasz Adam Modzelewski BRD	Director/Board Member	57	20/07/2017
Agnieszka Maslowska BRD	Director/Board Member	-	20/07/2017
Michal Krzysztof Kowalczewski CHM	Chairman	54	20/07/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
POLI BANK	-.--%	+0.22%	-	-	198M
CVS HEALTH CORPORATION	+3.03%	+0.62%	+52.17%	+45.94%	125B
HCA HEALTHCARE, INC.	+0.49%	-3.33%	-0.14%	+28.05%	83.23B
FRESENIUS SE & CO. KGAA	-0.18%	+1.78%	-5.88%	+58.16%	25.59B
QUEST DIAGNOSTICS INCORPORATED	-0.73%	-4.25%	+7.89%	+39.48%	21.59B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-2.28%	-2.15%	-14.33%	-25.23%	20.42B
TENET HEALTHCARE CORPORATION	+3.58%	-0.20%	+6.39%	+125.64%	14.86B
REDE D'OR SÃO LUIZ S.A.	+0.68%	+0.09%	-2.79%	+2.73%	14.38B
DAVITA INC.	+0.85%	-0.03%	+53.12%	+111.88%	13.35B
FRESENIUS MEDICAL CARE AG	+1.35%	+1.35%	-11.27%	-5.04%	12.54B
Average	+0.68%	-0.52%	+9.46%	+42.40%	36.82B
Weighted average by Cap.	+1.34%	-1.13%	+20.77%	+40.01%

POLI BANK Share Price

Stocks

BKM

PLPBKM000012

Healthcare Facilities & Services

Latest news : POLI BANK

Press Releases: POLI BANK

Managers and Directors: POLI BANK

Other Healthcare Facilities & Services

Company Profile